GSK vets Witty and Slaoui find new roles in biotech as the great migration continues
⇨ Andrew Witty has signed on as a partner at Durham, NC-based Hatteras. “Andrew Witty we believe brings the highest level of understanding about the pharma industry as a whole,” Hatteras general partner Bob Ingram tells Endpoints News, counting off Witty’s leading roles in the global commercial as well as R&D side of the business. Ingram says Witty — likely the only knighted member of the biotech venture community — is expected to help advise the firm and its biotech companies, lending some of his sterling Big Pharma rep to the organization as it grows up new companies. And, you can add one more new biotech role for ex-GSK CEO. The former pharma chief has joined the advisory board at Synthego, a genome engineering outfit based in Redwood City, CA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.